The United States Plasma Fractionation Market Size is anticipated to exceed USD 34.5 Billion by 2033, Growing at a CAGR of 7.02% from 2023 to 2033. The growing prevalence of immunodeficiency disorder and rising demand for plasma-derived products for treatment are driving the growth of the plasma fractionation market in the US. Plasma fractionation is the process of separating components of blood plasma to manufacture valuable products from plasma.